NF-kB signaling in the control of Hematopoiesis

NF-kB 信号传导在造血控制中的作用

基本信息

项目摘要

Project Summary: NF-κB signaling pathway is one of the most extensively studied and understood pathways, however, the physiological impact of augmented NF-κB signaling in hematopoiesis has not been understood. Despite many recent studies documenting constitutive activation of NF-κB in patients with hematological disorders, including AML and MDS, it is remains unclear if constitutive NF-κB signaling is sufficient and/or necessary for the onset of the disease. Recently, we have shown that lack of A20 (a negative regulator of NF-κB) in hematopoietic stem cells (HSCs) causes loss of quiescence and severe hematologic abnormalities, due to constitutive NF-κB activation. In an attempt to decipher the role of NF-κB in HSCs, directly , we engineered mice to constitutively activate NF-κB in HSCs. Our preliminary data indicate that HSC quiescence and pool were completely lost, and that increased NF-κB signal alone was sufficient to disturb the transcriptional regulatory circuits of HSCs. In the proposed research, we would like to decode the potential molecular mechanisms through which increased NF-κB signals affect HSC biology. Our hypothesis is that deregulated canonical NF-κB signals impair hematopoietic stem cell (HSC) quiescence and functions by altering signal transduction pathways, `transcription factor networks' and expression of pro-inflammatory cytokines. To test this hypothesis, we will use a combination of genetic, molecular cell biology and biochemical approaches. In specific aim 1, we will decipher the intrinsic mechanisms through which NF-κB affects HSC functions. In specific aim 2, we will unravel the extrinsic role of NF-κB in the control of HSCs. In specific aim 3, we would generate a novel humanized mouse model and decode the involvement of NF-κB signals in human HSC biology. We believe that the proposed research will provide key insights into the pathologic processes involving deregulated NF-κB signals, and will aid the development of newer and more successful therapies for human hematologic diseases that arise due to constitutive NF-κB activation.
项目概要: NF-κB 信号通路是研究和理解最广泛的信号通路之一 然而,增强 NF-κB 信号传导的生理影响 造血作用尚未被了解。尽管最近许多研究记录 血液系统疾病(包括 AML)患者中 NF-κB 的组成型激活 和 MDS,目前尚不清楚组成型 NF-κB 信号传导是否足够和/或 疾病发生所必需的。最近,我们发现缺乏 A20(a 造血干细胞 (HSC) 中的 NF-κB 负调节因子会导致 由于 NF-κB 的持续激活,导致静止期和严重的血液学异常。 为了直接破译 NF-κB 在 HSC 中的作用,我们对小鼠进行了改造 持续激活 HSC 中的 NF-κB。我们的初步数据表明 HSC 静止和池完全消失,仅增加 NF-κB 信号 足以干扰 HSC 的转录调节回路。在提议的 研究,我们想解码潜在的分子机制 NF-κB 信号增加会影响 HSC 生物学。 我们的假设是,规范 NF-κB 信号失调会损害造血功能 干细胞 (HSC) 静止并通过改变信号转导发挥作用 通路、“转录因子网络”和促炎因子的表达 细胞因子。为了检验这个假设,我们将结合遗传、分子细胞 生物学和生化方法。在具体目标1中,我们将破译内在的 NF-κB 影响 HSC 功能的机制。在具体目标2中,我们将 揭示 NF-κB 在 HSC 控制中的外在作用。在具体目标 3 中,我们将 生成新型人源化小鼠模型并解码 NF-κB 的参与 人类 HSC 生物学中的信号。 我们相信,拟议的研究将为以下问题提供重要见解: 涉及失调 NF-κB 信号的病理过程,并将有助于发育 针对人类血液疾病的更新、更成功的疗法 NF-κB 的组成型激活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chozha Vendan Rathinam其他文献

Chozha Vendan Rathinam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chozha Vendan Rathinam', 18)}}的其他基金

NF-kB signaling in the control of Hematopoiesis
NF-kB 信号传导在造血控制中的作用
  • 批准号:
    10087951
  • 财政年份:
    2017
  • 资助金额:
    $ 38.58万
  • 项目类别:
GENETIC & MOLECULAR CONTROL OF E3 UBIQUITIN LIGASES IN STEM DIFFERENTIATION
基因
  • 批准号:
    8360045
  • 财政年份:
    2011
  • 资助金额:
    $ 38.58万
  • 项目类别:

相似海外基金

Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
  • 批准号:
    19K08356
  • 财政年份:
    2019
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
在急性髓细胞白血病中使用超靶向单克隆抗体产生免疫毒素
  • 批准号:
    23501309
  • 财政年份:
    2011
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
  • 批准号:
    3556971
  • 财政年份:
    1980
  • 资助金额:
    $ 38.58万
  • 项目类别:
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
  • 批准号:
    3556968
  • 财政年份:
    1980
  • 资助金额:
    $ 38.58万
  • 项目类别:
ERADICATION OF ACUTE MYELOCYTIC LEUKEMIA CELLS BY MAB THERAPY
通过 MAB 疗法根除急性粒细胞白血病细胞
  • 批准号:
    3889304
  • 财政年份:
  • 资助金额:
    $ 38.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了